Clinical efficacy of acetylcysteine combined with tetrandrine tablets on patients with silicosis and its effect on exercise tolerance and pulmonary function

Guo,Xiuzhi; Qi,Jing; Li,Huanxiang; Xing,Zhaofeng

doi:10.3892/etm.2020.8858

Clinical efficacy of acetylcysteine combined with tetrandrine tablets on patients with silicosis and its effect on exercise tolerance and pulmonary function

Authors:
- Xiuzhi Guo
- Jing Qi
- Huanxiang Li
- Zhaofeng Xing
View Affiliations

Affiliations: Department II of Occupational Disease, Branch of Tai'an City Central Hospital, Tai'an, Shandong 271000, P.R. China, Department of Public Health, Branch of Tai'an City Central Hospital, Tai'an, Shandong 271000, P.R. China, Occupational Disease Diagnosis, Branch of Tai'an City Central Hospital, Tai'an, Shandong 271000, P.R. China
Published online on: June 10, 2020 https://doi.org/10.3892/etm.2020.8858
Pages: 1285-1290
Copyright: © Guo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Clinical efficacy of acetylcysteine combined with tetrandrine tablets in the treatment of silicosis was investigated to observe the exercise tolerance and pulmonary function of the patients. The clinical data of 248 cases of silicosis patients treated in Branch of Tai'an City Central Hospital were retrospectively analyzed in this study, including 116 cases with conventional therapy (control group), and 132 cases treated with acetylcysteine and tetrandrine tablets on the basis of conventional therapy (observation group). The chest tightness, chest pain, cough and sputum production were evaluated by the St. George Respiratory questionnaire (SGRQ); and side effects after treatment were recorded. Exercise tolerance was measured by 6‑min walk test (6MWT) and pulmonary function was measured by pulmonary function instrument. The symptoms of chest tightness, chest pain, cough and sputum production in the observation group and the control group after 8 months of treatment were significantly lower than those before treatment (P<0.05), and that in the observation group after treatment was significantly higher than that in the control group (P<0.05). The incidence of side effects of the drug in the observation group was significantly lower than that in the control group (P<0.05). The 6MWT, forced vital capacity (FVC) and forced expiratory volume in 1 sec (FEV1) in the observation group and the control group after treatment were significantly higher than those before treatment (P<0.001); the 6MWT in the observation group after treatment was significantly higher than that in the control group (P<0.001). In conclusion, acetylcysteine combined with tetrandrine tablets on the basis of conventional therapy in treatment of silicosis is more effective than conventional therapy alone, which can also improve exercise tolerance, pulmonary function and clinical symptoms such as chest tightness, chest pain, cough, sputum production of silicosis patients, and is helpful for clinical application.

View Figures

View References

1	Akgün M and Ergan B: Silicosis in Turkey: Is it an endless nightmare or is there still hope? Turk Thorac J. 19:89–93. 2018.PubMed/NCBI View Article : Google Scholar
2	Brhel P, Petrovová M and Lorenzová D: Ventilatory function in patients with silicosis or coal workers' pneumoconiosis. Vnitr Lek. 61:1023–1027. 2015.PubMed/NCBI(In Czech).
3	Rimal B, Greenberg AK and Rom WN: Basic pathogenetic mechanisms in silicosis: Current understanding. Curr Opin Pulm Med. 11:169–173. 2005.PubMed/NCBI View Article : Google Scholar
4	Richter K and Kietzmann T: Reactive oxygen species and fibrosis: Further evidence of a significant liaison. Cell Tissue Res. 365:591–605. 2016.PubMed/NCBI View Article : Google Scholar
5	Peng HB, Wang RX, Deng HJ, Wang YH, Tang JD, Cao FY and Wang JH: Protective effects of oleanolic acid on oxidative stress and the expression of cytokines and collagen by the AKT/NFκB pathway in silicotic rats. Mol Med Rep. 15:3121–3128. 2017.PubMed/NCBI View Article : Google Scholar
6	Huaux F: New developments in the understanding of immunology in silicosis. Curr Opin Allergy Clin Immunol. 7:168–173. 2007.PubMed/NCBI View Article : Google Scholar
7	Gurjar D, Gupta M, Sharma H and Pathak S: Study to find out the efficacy of 6 minute walk test in assessing response to medical intervention in chronic obstructive pulmonary disease patients. IJAM. 3(3)2019.
8	Saglam M, Vardar-Yagli N, Savci S, Inal-Ince D, Calik-Kutukcu E, Arikan H and Coplu L: Functional capacity, physical activity, and quality of life in hypoxemic patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 10:423–428. 2015.PubMed/NCBI View Article : Google Scholar
9	Yeh ST, Guo HR, Su YS, Lin HJ, Hou CC, Chen HM, Chang MC and Wang YJ: Protective effects of nacetylcysteine treatment post acute paraquat intoxication in rats and in human lung epithelial cells. Toxicology. 223:181–190. 2006.PubMed/NCBI View Article : Google Scholar
10	McLaughlin MF, Donoviel DB and Jones JA: Novel indications for commonly used medications as radiation protectants in spaceflight. Aerosp Med Hum Perform. 88:665–676. 2017.PubMed/NCBI View Article : Google Scholar
11	Li FQ, Lu B, Chen WB and Yang H: Tetrandrine loaded sustainedrelease microcapsules for lung targeting. Yao Xue Xue Bao. 36:220–223. 2001.PubMed/NCBI(In Chinese).
12	Liu C, Gong X, Xiao X, Yuan X and Cai B: Effects of tetrandrine combined with large volume whole lung lavage on the quality of life and oxidative stress of pneumoconiosis patients. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 32:219–221. 2014.PubMed/NCBI(In Chinese).
13	Suut S, Al-Ani Z, Allen C, Rajiah P, Durr-E-Sabih Al-Harbi A, Al-Jahdali H and Khan AN: Pictorial essay of radiological features of benign intrathoracic masses. Ann Thorac Med. 10:231–242. 2015.PubMed/NCBI View Article : Google Scholar
14	Reychler G, Audag N, Mestre NM and Caty C: Assessment of validity and reliability of the 1-minute sit-to-stand test to measure the heart rate response to exercise in healthy children. JAMA pediatr. 173:692–693. 2019.PubMed/NCBI View Article : Google Scholar
15	Ringbaek T, Martinez G and Lange P: A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD. 9:12–15. 2012.PubMed/NCBI View Article : Google Scholar
16	Ora J, Calzetta L, Pezzuto G, Senis L, Paone G, Mari A, Portalone S, Rogliani P, Puxeddu E and Saltini C: A 6MWT index to predict O₂ flow correcting exercise induced SpO₂ desaturation in ILD. Respir Med. 107(20142021)2013.PubMed/NCBI View Article : Google Scholar
17	Huff JE, Dinger CY, Kline BW, Whitfield BL and Hammons AS: A health view of asbestos: An annotated literature collection. 1960-1974. Environ Health Perspect. 9:341–462. 1975.PubMed/NCBI View Article : Google Scholar
18	Zhang Y, Yang F, Liu Y, Peng HB, Geng YC, Li SF, Xu H, Zhu LY, Yang XH and Brann D: Influence of the interaction between Ac-SDKP and Ang II on the pathogenesis and development of silicotic fibrosis. Mol Med Rep. 17:7467–7476. 2018.PubMed/NCBI View Article : Google Scholar
19	Wang SX, Liu P, Wei MT, Chen L, Guo Y, Wang RY, Tu ZG and Liang XC: Roles of serum clara cell protein 16 and surfactant protein D in the early diagnosis and progression of silicosis. J Occup Environ Med. 49:834–839. 2007.PubMed/NCBI View Article : Google Scholar
20	Weiss DJ, Chambers D, Giangreco A, Keating A, Kotton D, Lelkes PI, Wagner DE and Prockop DJ: ATS Subcommittee on Stem Cells and Cell Therapies. An official American Thoracic Society workshop report: Stem cells and cell therapies in lung biology and diseases. Ann Am Thorac Soc. 12:79–97. 2015.PubMed/NCBI View Article : Google Scholar
21	Luckhardt TR, Müller-Quernheim J and Thannickal VJ: Update in diffuse parenchymal lung disease 2011. Am J Respir Crit Care Med. 186:24–29. 2012.PubMed/NCBI View Article : Google Scholar
22	Ning JX, Zhang LP and Cui Y: Evaluation of clinical efficacy of tretrandrine combined with acetylcysteine effervescent tablets in the treatment of silicosis. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 35:298–299. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).
23	Zhang L, He YL, Li QZ, Hao XH, Zhang ZF, Yuan JX, Bai YP, Jin YL, Liu N, Chen G, et al: Nacetylcysteine alleviated silica induced lung fibrosis in rats by downregulation of ROS and mitochondrial apoptosis signaling. Toxicol Mech Methods. 24:212–219. 2014.PubMed/NCBI View Article : Google Scholar
24	Li C, Lu Y, Du S, Li S, Zhang Y, Liu F, Chen Y, Weng D and Chen J: Dioscin exerts protective effects against crystalline silica-induced pulmonary fibrosis in mice. Theranostics. 7:4255–4275. 2017.PubMed/NCBI View Article : Google Scholar
25	Cai XH, Wang S and Chen BA: Research advances on the pharmacological effects of tetrandrine. Chin J Nat Med. 9:473–480. 2011.
26	Bhagya N and Chandrashekar KR: Tetrandrine - A molecule of wide bioactivity. Phytochemistry. 125:5–13. 2016.PubMed/NCBI View Article : Google Scholar
27	Weiss DJ, Bates JH, Gilbert T, Liles WC, Lutzko C, Rajagopal J and Prockop D: Stem cells and cell therapies in lung biology and diseases: Conference report. Ann Am Thorac Soc. 10:S25–S44. 2013.PubMed/NCBI View Article : Google Scholar